Sonic Healthcare (ASX:SHL) has officially received unconditional clearance from German antitrust authorities to proceed with the acquisition of LADR – Laboratory Group Dr. Kramer & Colleagues.
The company expects to finalise the transaction on July 1.
This follows Sonic Healthcare's initial market disclosure regarding the acquisition on Dec. 9, 2024.
The acquisition is expected to strengthen Sonic Healthcare’s European operations and enhance its diagnostic service capabilities across Germany.
Sonic Healthcare is an ASX-listed healthcare provider engaged in laboratory medicine/pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America.